Filter
399
Text search:
co-morbidities
Featured
48
96
Language
Document type
189
97
61
18
14
13
3
2
1
1
Countries
34
21
18
16
14
12
11
9
9
8
8
7
7
6
6
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
182
52
22
6
5
5
Toolboxes
70
65
28
27
21
11
8
8
7
5
4
4
3
3
2
2
1
1
1
1
1
1
1
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Accessed November 2017
Accessed November 2017
Accessed November 2017
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326
4–15 February 2013
This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
